Between the countries which have ordered Chinese or Russian vaccines not validated by the EU and those which have relied on the AstraZeneca vaccine, whose doses are long overdue, the situation in several eastern states worries the European Union, in a context of free movement of people. 

DECRYPTION

While Europe has just passed the milestone of one million deaths from Covid-19, there is a lot of talk about the successive waves in France, Germany and Spain.

But little is known: among the countries where the epidemic is wreaking havoc, many are in the East, such as the Czech Republic, Bulgaria, Hungary and Slovenia.

Many of these countries have one thing in common: that of having bought Russian and Chinese vaccines that do not work.

And the situation could become problematic for the whole of the European Union, a common area of ​​free movement. 

>> LIVE

 -

 Coronavirus: follow the evolution of the situation Wednesday April 14

A health certificate to promote vaccines recognized in Europe

Two major problems have been identified.

First, some countries have relied on vaccines not validated by the European Medicines Agency.

This is especially the case in Hungary, where a million people have been vaccinated with Chinese Sinopharm, the effectiveness of which is disputed today.

The Czechs and Slovaks, for their part, are waiting for deliveries of Russian Sputniks.

The European response on this point will be the health certificate that the 27 are preparing for the end of June.

To cross borders and come to France, for example, only vaccines recognized in Europe will be valid.

Not enough dose in some eastern countries

Second problem: other eastern countries do not vaccinate enough.

Bulgaria or Latvia, for example, vaccinated half as much as the European average.

These countries had relied on AstraZeneca and not on the more expensive messenger RNA vaccines, so they have fewer doses.

>> INFORMATION EUROPE 1 -

Several complaints filed for suspected side effects of the AstraZeneca vaccine

There, the answer consists in greater European solidarity.

Recently, five Eastern European countries have received more doses of Pfizer than they normally should have received.